| Lastest Insider Transactions Of Edgewise Therapeutics, Inc. ( EWTX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| EWTX | Edgewise Therapeutics, Inc. | Edris Badreddin | Directior | 2026-01-21 | Sell | 115,471 | 29.44 | 3,399,466 | 2026-01-23 13:34:18 |
| EWTX | Edgewise Therapeutics, Inc. | Edris Badreddin | Directior | 2026-01-21 | Option Exercise | 115,471 | 1.47 | 170,264 | 2026-01-23 13:34:18 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-11-12 | Sell | 100,000 | 21.12 | 2,112,450 | 2025-11-13 18:06:38 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-11-12 | Option Exercise | 100,000 | 0.18 | 18,000 | 2025-11-13 18:06:38 |
| EWTX | Edgewise Therapeutics, Inc. | Fox Jonathan C | Directior | 2025-11-11 | Buy | 10,700 | 18.64 | 199,403 | 2025-11-13 18:04:59 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-08-26 | Sell | 100,000 | 14.60 | 1,459,760 | 2025-08-28 16:55:53 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-08-26 | Option Exercise | 100,000 | 0.18 | 18,000 | 2025-08-28 16:55:53 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2025-08-12 | Sell | 2,098 | 13.39 | 28,097 | 2025-08-14 19:43:39 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2025-08-12 | Option Exercise | 5,781 | 0.00 | 0 | 2025-08-14 19:43:39 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-08-12 | Sell | 2,491 | 13.39 | 33,360 | 2025-08-14 19:43:22 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-08-12 | Option Exercise | 5,781 | 0.00 | 0 | 2025-08-14 19:43:22 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-08-12 | Sell | 2,491 | 13.39 | 33,360 | 2025-08-14 19:43:22 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-08-12 | Option Exercise | 5,781 | 0.00 | 0 | 2025-08-14 19:43:22 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2025-08-12 | Sell | 1,428 | 13.39 | 19,124 | 2025-08-14 19:43:04 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2025-08-12 | Option Exercise | 5,781 | 0.00 | 0 | 2025-08-14 19:43:04 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-08-12 | Sell | 1,907 | 13.39 | 25,539 | 2025-08-14 19:42:38 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-08-12 | Option Exercise | 5,781 | 0.00 | 0 | 2025-08-14 19:42:38 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-08-12 | Sell | 1,907 | 13.39 | 25,539 | 2025-08-14 19:42:38 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-08-12 | Option Exercise | 5,781 | 0.00 | 0 | 2025-08-14 19:42:38 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-08-12 | Sell | 7,972 | 13.39 | 106,764 | 2025-08-14 19:42:14 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-08-12 | Option Exercise | 17,968 | 0.00 | 0 | 2025-08-14 19:42:14 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2025-08-12 | Sell | 2,862 | 13.39 | 38,329 | 2025-08-14 19:41:55 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2025-08-12 | Option Exercise | 5,781 | 0.00 | 0 | 2025-08-14 19:41:55 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-05-01 | Sell | 1,551 | 16.45 | 25,520 | 2025-05-07 21:10:58 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-05-01 | Option Exercise | 5,209 | 0.00 | 0 | 2025-05-07 21:10:58 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2025-05-01 | Sell | 1,930 | 16.45 | 31,757 | 2025-05-07 21:10:38 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2025-05-01 | Option Exercise | 5,209 | 0.00 | 0 | 2025-05-07 21:10:38 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-05-01 | Sell | 4,276 | 16.45 | 70,358 | 2025-05-07 21:10:20 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-05-01 | Option Exercise | 10,417 | 0.00 | 0 | 2025-05-07 21:10:20 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2025-05-01 | Sell | 5,187 | 16.45 | 85,348 | 2025-05-07 21:09:49 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2025-05-01 | Option Exercise | 10,417 | 0.00 | 0 | 2025-05-07 21:09:49 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-05-01 | Sell | 1,691 | 16.45 | 27,824 | 2025-05-07 21:09:15 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-05-01 | Option Exercise | 5,209 | 0.00 | 0 | 2025-05-07 21:09:15 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2025-05-01 | Sell | 1,314 | 16.45 | 21,621 | 2025-05-07 21:08:44 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2025-05-01 | Option Exercise | 5,209 | 0.00 | 0 | 2025-05-07 21:08:44 |
| EWTX | Edgewise Therapeutics, Inc. | Thompson Peter A. | Directior 10% Owner | 2025-04-03 | Buy | 496,771 | 20.13 | 10,000,000 | 2025-04-04 19:42:30 |
| EWTX | Edgewise Therapeutics, Inc. | ORBIMED ADVISORS LLC | Directior 10% Owner | 2025-04-03 | Buy | 496,771 | 20.13 | 10,000,000 | 2025-04-04 19:33:31 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-03-07 | Sell | 200 | 30.02 | 6,004 | 2025-03-11 16:33:15 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-03-07 | Option Exercise | 200 | 0.18 | 36 | 2025-03-11 16:33:15 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-03-07 | Sell | 100 | 30.00 | 3,000 | 2025-03-11 16:32:38 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-03-07 | Option Exercise | 100 | 0.18 | 18 | 2025-03-11 16:32:38 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-02-05 | Sell | 9,215 | 30.04 | 276,776 | 2025-02-07 16:38:15 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2025-02-05 | Option Exercise | 9,215 | 0.18 | 1,659 | 2025-02-07 16:38:15 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-02-05 | Sell | 9,536 | 30.13 | 287,316 | 2025-02-07 16:38:11 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2025-02-05 | Option Exercise | 9,536 | 1.40 | 13,353 | 2025-02-07 16:38:11 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-02-05 | Sell | 10,000 | 30.03 | 300,300 | 2025-02-07 16:37:56 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2025-02-05 | Option Exercise | 10,000 | 1.93 | 19,300 | 2025-02-07 16:37:56 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2025-01-28 | Sell | 25,000 | 27.63 | 690,658 | 2025-01-30 16:05:36 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2025-01-28 | Option Exercise | 25,000 | 7.08 | 177,000 | 2025-01-30 16:05:36 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2024-12-30 | Sell | 100,000 | 27.37 | 2,737,470 | 2024-12-31 17:13:19 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2024-12-30 | Option Exercise | 100,000 | 0.18 | 18,000 | 2024-12-31 17:13:19 |
| EWTX | Edgewise Therapeutics, Inc. | Semigran Marc | Chief Development Officer | 2024-12-24 | Sell | 29,709 | 29.69 | 881,915 | 2024-12-27 16:30:04 |
| EWTX | Edgewise Therapeutics, Inc. | Semigran Marc | Chief Development Officer | 2024-12-24 | Option Exercise | 29,709 | 8.94 | 265,598 | 2024-12-27 16:30:04 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2024-10-11 | Option Exercise | 70,000 | 0.71 | 49,700 | 2024-10-16 16:23:23 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2024-09-20 | Sell | 75,000 | 28.27 | 2,120,101 | 2024-09-24 20:25:46 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2024-09-20 | Option Exercise | 75,000 | 0.18 | 13,500 | 2024-09-24 20:25:46 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2024-09-20 | Sell | 70,922 | 28.15 | 1,996,574 | 2024-09-24 20:25:15 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2024-09-20 | Option Exercise | 70,922 | 0.71 | 50,355 | 2024-09-24 20:25:15 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2024-09-20 | Sell | 7,162 | 28.29 | 202,603 | 2024-09-24 20:24:38 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2024-09-20 | Sell | 42,068 | 29.03 | 1,221,133 | 2024-09-24 20:24:05 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2024-09-20 | Option Exercise | 42,068 | 1.93 | 81,191 | 2024-09-24 20:24:05 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2024-09-20 | Sell | 125,092 | 28.57 | 3,573,980 | 2024-09-24 20:22:56 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2024-09-20 | Option Exercise | 96,068 | 1.93 | 185,411 | 2024-09-24 20:22:56 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2024-05-01 | Sell | 1,956 | 18.91 | 36,988 | 2024-05-03 18:31:04 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2024-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2024-05-03 18:31:04 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2024-05-01 | Sell | 2,157 | 18.91 | 40,789 | 2024-05-03 18:30:08 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2024-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2024-05-03 18:30:08 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2024-05-01 | Sell | 1,718 | 18.91 | 32,487 | 2024-05-03 18:29:16 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2024-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2024-05-03 18:29:16 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2024-05-01 | Sell | 1,576 | 18.91 | 29,802 | 2024-05-03 18:28:24 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2024-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2024-05-03 18:28:24 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2024-05-01 | Sell | 3,682 | 18.91 | 69,627 | 2024-05-03 18:27:48 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2024-05-01 | Option Exercise | 10,417 | 0.00 | 0 | 2024-05-03 18:27:48 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2024-05-01 | Sell | 3,152 | 18.91 | 59,604 | 2024-05-03 18:26:53 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2024-05-01 | Option Exercise | 10,417 | 0.00 | 0 | 2024-05-03 18:26:53 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2024-02-07 | Sell | 29,835 | 20.00 | 596,805 | 2024-02-09 17:43:27 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2024-02-07 | Option Exercise | 29,835 | 1.93 | 57,582 | 2024-02-09 17:43:27 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2024-02-07 | Sell | 10,000 | 20.03 | 200,258 | 2024-02-09 17:42:31 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2024-02-07 | Option Exercise | 10,000 | 1.93 | 19,300 | 2024-02-09 17:42:31 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2024-01-23 | Sell | 90,000 | 15.78 | 1,419,759 | 2024-01-25 16:46:26 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2024-01-23 | Option Exercise | 90,000 | 1.93 | 173,700 | 2024-01-25 16:46:26 |
| EWTX | Edgewise Therapeutics, Inc. | Thompson Peter A. | Directior 10% Owner | 2024-01-23 | Buy | 454,545 | 11.00 | 4,999,995 | 2024-01-25 16:32:07 |
| EWTX | Edgewise Therapeutics, Inc. | ORBIMED ADVISORS LLC | Directior 10% Owner | 2024-01-23 | Buy | 454,545 | 11.00 | 4,999,995 | 2024-01-25 16:28:46 |
| EWTX | Edgewise Therapeutics, Inc. | Fox Jonathan C | Directior | 2023-12-26 | Buy | 10,857 | 9.30 | 100,958 | 2023-12-28 16:39:30 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2023-12-27 | Sell | 8,497 | 10.50 | 89,219 | 2023-12-28 16:39:04 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2023-12-26 | Sell | 172,585 | 9.33 | 1,610,097 | 2023-12-28 16:38:37 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2023-06-22 | Option Exercise | 10,000 | 0.71 | 7,100 | 2023-06-26 16:28:45 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2023-05-01 | Sell | 1,747 | 8.90 | 15,557 | 2023-05-03 18:26:49 |
| EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | 2023-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2023-05-03 18:26:49 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2023-05-01 | Sell | 1,897 | 8.90 | 16,893 | 2023-05-03 18:26:36 |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | 2023-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2023-05-03 18:26:36 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2023-05-01 | Sell | 1,336 | 8.90 | 11,897 | 2023-05-03 18:26:15 |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | 2023-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2023-05-03 18:26:15 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2023-05-01 | Sell | 1,602 | 8.90 | 14,266 | 2023-05-03 18:26:08 |
| EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | 2023-05-01 | Option Exercise | 5,208 | 0.00 | 0 | 2023-05-03 18:26:08 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2023-05-01 | Sell | 3,254 | 8.90 | 28,977 | 2023-05-03 18:25:48 |
| EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | 2023-05-01 | Option Exercise | 10,416 | 0.00 | 0 | 2023-05-03 18:25:48 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2023-05-01 | Sell | 3,203 | 8.90 | 28,522 | 2023-05-03 18:25:43 |
| EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | President and CEO | 2023-05-01 | Option Exercise | 10,416 | 0.00 | 0 | 2023-05-03 18:25:43 |
